River’s Edge Hospital is excited to offer Genius™ 3D Mammography™ exams, developed by Hologic, Inc., a worldwide leader inWomen’s Health. [i] Utilizing advanced breast tomosynthesis technology, Genius exams are clinically proven to significantly increase the detection of breast cancers, and also decreasing the number of women asked to return for additional testing.1-7 To learn more watch the video on the River’s Edge Hospital YouTube channel
In conventional 2D Mammography, overlapping tissue is a leading reason why small breast cancers may be missed and normal tissue may appear abnormal, leading to unnecessary callbacks. A Genius exam includes a three-dimensional method of imaging that can greatly reduce the tissue overlap effect.
“ The Mammography staff at River’s Edge is excited to be able to offer the best breast cancer screening tool available. 3D mammograms will not only allow us to find early cancers quickly, but will also decrease the likelihood that a women would have to come back for additional imaging,” said Kim Henze, Imaging Services Manager at River’s Edge Hospital.
A Genius exam includes both 2D images and tomosynthesis
scans. During the tomosynthesis-DIMENSIONAL
portion of the exam, an X-ray arm
sweeps in a slight
arc over the breast, taking
multiple images. A computer then
converts the images into a stack of thin layers, allowing the radiologist to
review the breast tissue one layer at a time. A Genius exam requires no
additional compression and takes just a few seconds longer than a conventional
2D breast cancer screening exam.
Our Genius™ 3D Mammography™ exam, available on the
3Dimensions™ and Selenia® Dimensions® systems from Hologic, are revolutionizing
how breast cancer is detected by providing a better option for women of all
breast densities compared to 2D alone.1-2 Researchers have found that:
- The Genius™ 3D Mammography™ exam finds 20-65% more
invasive breast cancers compared to 2D alone, an average increase of 41%.3
- Only the Genius™ 3D Mammography™ exam is FDA approved as
superior for women with dense breasts compared to 2D alone.1-2
- The Genius™ 3D Mammography™ exam reduces callbacks by up
to 40% compared to 2D alone.2,4
River’s Edge Hospital is
committed to the fight against breast cancer. In offering the Genius exam,
River’s Edge Hospital provides a more accurate tool for breast cancer
If you would like to schedule a
Genius 3D Mammography™ exam, or have questions about this important breast
health procedure, please contact us at 507-931-2200.
About Genius™ 3D Mammography™ Exams
The breast is a three-dimensional object composed of
different structures located at different heights within the breast. These
structures can overlap and cause confusion when viewed as a flat
two-dimensional image. This confusion of overlapping of tissue is a leading
reason why small breast cancers may be missed and normal tissue may appear
abnormal, leading to unnecessary callbacks. Using breast tomosynthesis
technology, the Hologic system creates a 3-dimensional image of the breast
structure, which enables radiologists to more clearly see through overlapping
tissue to detect cancers, often at an earlier stage.
The Hologic system is the first FDA-approved breast
tomosynthesis system in the U.S. Hologic Genius 3D Mammography™ exams are now
available in all 50 states and over 50 countries. To date, more than 8 million
women have been screened with this advanced screening system.
The Genius™ 3D Mammography™ (a.k.a. Genius™ exam) is acquired on the
Hologic® 3D Mammography™ system and consists of a 2D and 3D™ image set, where
the 2D image can be either an acquired 2D image or a 2D image generated from
the 3D™ image set. The Genius™ exam is only available on the Hologic 3D
1) FDA submissions P080003, P080003/S001,
2) Friedewald SM, Rafferty EA, Rose SL, et al.
Breast cancer screening using tomosynthesis in combination with digital
mammography. JAMA. 2014 Jun
3) Results from
Friedewald, SM, et al. “Breast cancer screening using tomosynthesis in
combination with digital mammography.” JAMA
311.24 (2014): 2499 2507; a multi-site (13), non-randomized, historical
control study of 454,000 screening mammograms investigating the initial impact
the introduction of the Hologic Selenia® Dimensions ® on screening outcomes.
Individual results may vary. The study found an average 41% (95% CI: 20-65%)
increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per
1000 screening exams were found in women receiving combined 2D FFDM and 3D™
mammograms acquired with the Hologic 3D Mammography™ System versus women
receiving 2D FFDM mammograms only.
4) Bernardi D,
Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis
(3D mammography) with acquired or synthetic 2D mammography compared with 2D
mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
5) Bernardi D, Macaskill P, Pellegrini M, et. al.
Breast cancer screening with tomosynthesis(3D mammography) with acquired or
synthetic 2D mammography compared with 2D mammography alone (STORM-2): a
population-based prospective study. Lancet
Oncol. 2016 Aug;17(8):1105-13.
6) McDonald ES, Oustimov A, Weinstein SP, et
al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital
Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43.
7) Rafferty EA, Durand MA, Conant EF, et al
Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense
and Nondense Breasts. JAMA. 2016 Apr
MISC-05233 Rev 001 (5/18)